logo
Select company
Select metric
$ -105.9MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
7
Sector
18
Industry
26
History
71
$ 3.04Close
$ 0.9 - $ 6.06 52-Week Range
Ticker Information

Ticker

ALEC

Company Name

ALECTOR INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ALECTOR INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ALEC - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 9.34M$ -115.24M$ -105.9M
3/31/2025$ 8.4M$ -123.32M$ -114.92M
12/31/2024$ 8.84M$ -118.92M$ -110.08M
9/30/2024$ 9.02M$ -156.66M$ -147.64M
6/30/2024$ 9.09M$ -157.67M$ -148.58M
3/31/2024$ 9.04M$ -116.3M$ -107.26M
12/31/2023$ 8.85M$ -125.18M$ -116.33M
9/30/2023$ 8.7M$ -137.12M$ -128.41M
6/30/2023$ 8.49M$ -139.31M$ -130.82M
3/31/2023$ 8.31M$ -131.15M$ -122.84M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ALECTOR INC's latest trailing twelve months (TTM) EBITDA stands at $ -160.1M.
  • Over the past 5 years, ALECTOR INC's average EBITDA has been $ -112.39M.
  • The median EBITDA for ALECTOR INC during this period was $ -122.21M
  • ALECTOR INC reached its highest EBITDA over the past 5 years at $ 46.62M.
  • The lowest EBITDA recorded by ALECTOR INC in the same timeframe $ -204.38M

ALECTOR INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
SGMO : SANGAMO THERAPEUTICS INC $ -55.42MBDTX : BLACK DIAMOND THERAPEUTICS INC $ 14.78MTHTX : THERATECHNOLOGIES INC $ 7.31MENTA : ENANTA PHARMACEUTICALS INC $ -82.41MAGEN : AGENUS INC $ -69.99MPLX : PROTALIX BIOTHERAPEUTICS INC $ 10.55MSPRO : SPERO THERAPEUTICS INC $ -53.6MCSBR : CHAMPIONS ONCOLOGY INC $ 4.42MTRDA : ENTRADA THERAPEUTICS INC $ -73MCELU : CELULARITY INC $ -58.15M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for ALECTOR INC is calculated as follows: EBIT [ $ -168.58M ] + DepAmor [ $ 8.48M ]
(=) EBITDA [ $ -160.1M ]

ALEC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -204.38M

Minimum

Jun 30, 2021

$ 46.62M

Maximum

Jun 30, 2022

$ -112.39M

Average

$ -122.21M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.79M with a standard deviation of $ 166.94M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.79M
median$ 8.83M
std$ 166.94M